MZE001 / S-606001 An oral GYS1 inhibitor licensed to Shionogi for Pompe disease, intended to reduce disease-causing glycogen production in muscle.
Visit productCosigns Received
Be the first Cosign
Put your name behind MZE001 / S-606001.
Add it to your Products I use list and share why you use it.